Captiva Spine received FDA 510(k) clearance to market TirboLOX-L, a titanium lumbar cage featuring a dual-layer lattice structure with a micro-rough surface, dual porosity and open architecture.
TirboLOX-L’s structure is designed to reduce radiographic presence for clear imaging, and its high coefficient of friction supports immediate bidirectional fixation, according to the company.
The device incorporates Captiva’s Pivotec® Pivoting TLIF cage, which is designed to addresschallenges of controlling cage insertion and angle manipulation during minimally invasive procedures.
Source: Captiva Spine; Image courtesy of Captiva Spine
Captiva Spine received FDA 510(k) clearance to market TirboLOX-L, a titanium lumbar cage featuring a dual-layer lattice structure with a micro-rough surface, dual porosity and open architecture.
TirboLOX-L’s structure is designed to reduce radiographic presence for clear imaging, and its high coefficient of friction supports immediate...
Captiva Spine received FDA 510(k) clearance to market TirboLOX-L, a titanium lumbar cage featuring a dual-layer lattice structure with a micro-rough surface, dual porosity and open architecture.
TirboLOX-L’s structure is designed to reduce radiographic presence for clear imaging, and its high coefficient of friction supports immediate bidirectional fixation, according to the company.
The device incorporates Captiva’s Pivotec® Pivoting TLIF cage, which is designed to addresschallenges of controlling cage insertion and angle manipulation during minimally invasive procedures.
Source: Captiva Spine; Image courtesy of Captiva Spine
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
Captiva Spine received FDA 510(k) clearance to market TirboLOX-L, a titanium lumbar cage featuring a dual-layer lattice structure with a micro-rough surface, dual porosity and open architecture.
